• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定与肾上腺腺瘤中皮质醇分泌相关的基因表达谱。

Identification of gene expression profiles associated with cortisol secretion in adrenocortical adenomas.

机构信息

Institut National de la Santé et de la Recherche Médicale Unité 1016, 75014 Paris, France.

出版信息

J Clin Endocrinol Metab. 2013 Jun;98(6):E1109-21. doi: 10.1210/jc.2012-4237. Epub 2013 Mar 28.

DOI:10.1210/jc.2012-4237
PMID:23539725
Abstract

CONTEXT

The cortisol secretion of adrenocortical adenomas can be either subtle or overt. The mechanisms leading to the autonomous hypersecretion of cortisol are unknown.

OBJECTIVE

The objective of the study was to identify the gene expression profile associated with the autonomous and excessive cortisol secretion of adrenocortical adenomas.

PATIENTS AND METHODS

The transcriptome of 22 unilateral adrenocortical adenomas (5 nonsecreting, 6 subclinical cortisol producing, 11 cortisol producing) was studied and correlated with cortisol secretion. Phosphodiesterase 8B (PDE8B) expression was measured by Western blot.

RESULTS

Unsupervised clustering identified 2 groups of adenomas with a difference in secretion level (P = .008). Cluster 1 included only cortisol-producing adenomas (8 of 11), whereas cluster 2 was an admixture of the nonsecreting, the subclinical cortisol-secreting, and 3 of the 11 cortisol-secreting adenomas (Fisher exact, P = .002). This cluster was driven by genes related to cortisol secretion and to extracellular matrix. More than 3000 genes correlated with cortisol secretion. Among the positively correlated were the steroidogenic enzymes, genes involved in cholesterol metabolism, and glutathione S-transferases. Among the negatively correlated genes were genes related to transcripts translation and the transcription factor GATA-6. The PDE8B, which inactivates the protein kinase A pathway, unexpectedly showed the strongest positive correlation with cortisol secretion, confirmed by Western blot. The protein kinase A-activity to cAMP ratio was increased in adenomas with high PDE8B levels, suggesting counterregulation to limit downstream activation of the pathway.

CONCLUSION

The transcriptome of adrenocortical adenomas reveals a major association with cortisol secretion and identifies specific groups of genes implicated in steroid secretion, suggesting that cAMP signaling alterations might be frequent in cortisol-secreting adenomas.

摘要

背景

肾上腺皮质腺瘤的皮质醇分泌可以是微妙的,也可以是明显的。导致皮质醇自主分泌过多的机制尚不清楚。

目的

本研究旨在确定与肾上腺皮质腺瘤自主和过度皮质醇分泌相关的基因表达谱。

患者和方法

研究了 22 例单侧肾上腺皮质腺瘤(5 例无分泌,6 例亚临床皮质醇产生,11 例皮质醇产生)的转录组,并与皮质醇分泌相关。通过 Western blot 测量磷酸二酯酶 8B(PDE8B)的表达。

结果

无监督聚类确定了 2 组具有分泌水平差异的腺瘤(P =.008)。第 1 组仅包括皮质醇产生的腺瘤(11 例中的 8 例),而第 2 组是无分泌、亚临床皮质醇分泌和 11 例皮质醇分泌腺瘤中的 3 例的混合物(Fisher 确切检验,P =.002)。该聚类由与皮质醇分泌和细胞外基质相关的基因驱动。与皮质醇分泌相关的基因超过 3000 个。在正相关的基因中,有类固醇生成酶、参与胆固醇代谢的基因和谷胱甘肽 S-转移酶。在负相关的基因中,有与转录翻译和转录因子 GATA-6 相关的基因。出乎意料的是,磷酸二酯酶 8B(使蛋白激酶 A 途径失活)与皮质醇分泌呈最强的正相关,Western blot 验证了这一点。PDE8B 水平高的腺瘤中蛋白激酶 A-活性与 cAMP 的比值增加,表明存在代偿性调节以限制该途径下游的激活。

结论

肾上腺皮质腺瘤的转录组与皮质醇分泌有很大的关联,并确定了与类固醇分泌相关的特定基因群,提示 cAMP 信号改变可能在皮质醇分泌腺瘤中频繁发生。

相似文献

1
Identification of gene expression profiles associated with cortisol secretion in adrenocortical adenomas.鉴定与肾上腺腺瘤中皮质醇分泌相关的基因表达谱。
J Clin Endocrinol Metab. 2013 Jun;98(6):E1109-21. doi: 10.1210/jc.2012-4237. Epub 2013 Mar 28.
2
Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens.分泌皮质醇的良性肾上腺皮质腺瘤会产生少量雄激素。
Clin Endocrinol (Oxf). 2007 Jun;66(6):778-88. doi: 10.1111/j.1365-2265.2007.02810.x. Epub 2007 Apr 4.
3
cAMP signaling in cortisol-producing adrenal adenoma.产生皮质醇的肾上腺腺瘤中的环磷酸腺苷信号传导
Eur J Endocrinol. 2015 Oct;173(4):M99-106. doi: 10.1530/EJE-15-0353. Epub 2015 Jul 2.
4
PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.分泌皮质醇腺瘤和肾上腺增生中PRKACA突变:一项60例的单中心研究
Eur J Endocrinol. 2015 Jun;172(6):677-85. doi: 10.1530/EJE-14-1113. Epub 2015 Mar 6.
5
Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and growth of tumor cells.前阿立新和阿立新受体在分泌皮质醇的肾上腺皮质腺瘤中表达,并且阿立新在体外刺激肿瘤细胞的皮质醇分泌和生长。
J Clin Endocrinol Metab. 2005 Jun;90(6):3544-9. doi: 10.1210/jc.2004-2385. Epub 2005 Mar 29.
6
Steroid Profiling by LC-MS/MS in Nonsecreting and Subclinical Cortisol-Secreting Adrenocortical Adenomas.采用液相色谱-串联质谱法对非分泌性和亚临床皮质醇分泌性肾上腺皮质腺瘤进行类固醇分析。
J Clin Endocrinol Metab. 2015 Sep;100(9):3529-38. doi: 10.1210/JC.2015-1992. Epub 2015 Jul 10.
7
Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.鉴定出一个临床上同质的良性皮质醇分泌性肾上腺皮质肿瘤亚组,其特征为蛋白激酶A(PKA)亚基改变和高PKA活性。
Eur J Endocrinol. 2008 Jun;158(6):829-39. doi: 10.1530/EJE-07-0819.
8
Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.Wnt/β-catenin 通路在肾上腺皮质腺瘤中的激活常归因于体细胞 CTNNB1 激活突变,其与较大的无分泌功能的肿瘤相关:一项对分泌和非分泌皮质醇肿瘤的研究。
J Clin Endocrinol Metab. 2011 Feb;96(2):E419-26. doi: 10.1210/jc.2010-1885. Epub 2010 Nov 17.
9
GNAS mutations in adrenal aldosterone-producing adenomas.肾上腺醛固酮分泌性腺瘤中的GNAS突变
Endocr J. 2016;63(2):199-204. doi: 10.1507/endocrj.EJ15-0642. Epub 2016 Jan 6.
10
Can Imaging Predict Subclinical Cortisol Secretion in Patients With Adrenal Adenomas? A CT Predictive Score.影像学能否预测肾上腺腺瘤患者亚临床皮质醇分泌?CT 预测评分。
AJR Am J Roentgenol. 2017 Jul;209(1):122-129. doi: 10.2214/AJR.16.16965. Epub 2017 Apr 12.

引用本文的文献

1
Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches.轻度自主性皮质醇分泌:病理生理学、合并症及管理方法。
Nat Rev Endocrinol. 2024 Aug;20(8):460-473. doi: 10.1038/s41574-024-00984-y. Epub 2024 Apr 22.
2
PLK3 promotes the proneural-mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1.PLK3 通过转录调控 C5AR1 促进胶质母细胞瘤的神经前-间质转化。
Mol Biol Rep. 2023 Oct;50(10):8249-8258. doi: 10.1007/s11033-023-08716-7. Epub 2023 Aug 12.
3
Mistimed sleep and waking activity in humans disrupts glucocorticoid signalling transcripts and SP1, but not plasma cortisol rhythms.
人类睡眠和清醒活动时间不当会扰乱糖皮质激素信号转录本和SP1,但不会扰乱血浆皮质醇节律。
Front Physiol. 2022 Aug 17;13:946444. doi: 10.3389/fphys.2022.946444. eCollection 2022.
4
Platelet-derived growth factor D expression in adrenal cells is modulated by corticosteroids: putative role in adrenal suppression.血小板衍生生长因子 D 在肾上腺细胞中的表达受皮质类固醇调节:在肾上腺抑制中的推测作用。
Pediatr Res. 2023 Jan;93(1):97-101. doi: 10.1038/s41390-022-02094-9. Epub 2022 May 14.
5
Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside.轻度皮质醇增多症的病理生理学:从实验室到临床。
Int J Mol Sci. 2022 Jan 8;23(2):673. doi: 10.3390/ijms23020673.
6
Molecular Mechanisms of Functional Adrenocortical Adenoma and Carcinoma: Genetic Characterization and Intracellular Signaling Pathway.功能性肾上腺皮质腺瘤和癌的分子机制:基因特征与细胞内信号通路
Biomedicines. 2021 Jul 26;9(8):892. doi: 10.3390/biomedicines9080892.
7
Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome.原发性醛固酮增多症和肾上腺库欣综合征的分子基础
J Endocr Soc. 2020 Jun 29;4(9):bvaa075. doi: 10.1210/jendso/bvaa075. eCollection 2020 Sep 1.
8
Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study.糖皮质激素诱导的肾上腺抑制易感性的全基因组关联研究。
Lancet Respir Med. 2018 Jun;6(6):442-450. doi: 10.1016/S2213-2600(18)30058-4. Epub 2018 Mar 15.
9
Alterations of Phosphodiesterases in Adrenocortical Tumors.肾上腺皮质肿瘤中磷酸二酯酶的改变。
Front Endocrinol (Lausanne). 2016 Aug 30;7:111. doi: 10.3389/fendo.2016.00111. eCollection 2016.
10
A genetic and molecular update on adrenocortical causes of Cushing syndrome.肾上腺皮质功能亢进症的遗传和分子病因学研究进展。
Nat Rev Endocrinol. 2016 May;12(5):255-62. doi: 10.1038/nrendo.2016.24. Epub 2016 Mar 11.